Application YC di Forcyte Biotechnologies

Winter 2021Active

Forcyte Biotechnologies ha partecipato a Y Combinator nel batch Winter 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2021
Settore: HealthcareDiagnostics
Dimensione team: 5
Stato: Active
Lanciata: 2021

Founder

Ivan PushkarskyFounder
Dino Di CarloFounder

Cosa fa Forcyte Biotechnologies

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Application YC di Forcyte Biotechnologies, ricostruita

Domanda per Y Combinator

Forcyte Biotechnologies, batch Winter 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Forcyte Biotechnologies

Describe what your company does in 50 characters or less.

Discover drugs that control cell squeezing

What is your company going to make? Please describe your product and what it does or will do.

We built a drug discovery platform using patented bioMEMS technology that measures how strongly cells contract. By turning cell contraction into a quantifiable metric, we're able to screen hundreds of thousands of compounds against contractile human cells. This lets us map human mechanobiology and find drug candidates to treat diseases caused by abnormal cell squeezing, like asthma and fibrosis.

Where do you live now, and where would the company be based after YC?

We live in Los Angeles, CA, and after YC, the company will remain based here.

Explain your decision regarding location.

Los Angeles offers the biotech talent and research institutions we need, plus it's where our team and founders are rooted. We want to keep growing locally rather than move elsewhere after YC.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Forcyte Biotechnologies?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Forcyte Biotechnologies (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Forcyte Biotechnologies si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Forcyte Biotechnologies?

Forcyte Biotechnologies apparteneva al batch Winter 2021 di Y Combinator.

Chi ha fondato Forcyte Biotechnologies?

Forcyte Biotechnologies è stato fondato da Ivan Pushkarsky, Dino Di Carlo.

Cosa fa Forcyte Biotechnologies?

Discover drugs that control how much cells "squeeze" to treat disease

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Forcyte Biotechnologies, e di ogni altro batch YC, è in YC Insights.